ASMT
Basic information
Region (hg38): Y:1615059-1643081
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASMT gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 6 | |||||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 6 | 6 | 4 |
Variants in ASMT
This is a list of pathogenic ClinVar variants found in the ASMT region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
Y-1615250-C-A | ASMT-related disorder | Uncertain significance (Nov 13, 2023) | ||
Y-1623156-C-A | Uncertain significance (Dec 15, 2015) | |||
Y-1623310-A-G | not specified | Likely benign (Sep 05, 2017) | ||
Y-1624390-C-T | ASMT-related disorder | Likely benign (Mar 30, 2021) | ||
Y-1629941-T-C | Conflicting classifications of pathogenicity (Jul 31, 2024) | |||
Y-1632709-T-C | ASMT-related disorder | Benign (Feb 22, 2023) | ||
Y-1632771-C-G | ASMT-related disorder | Likely benign (Aug 10, 2021) | ||
Y-1633190-C-A | Uncertain significance (Aug 22, 2019) | |||
Y-1633209-G-A | not specified | Uncertain significance (Jul 31, 2024) | ||
Y-1636446-T-G | Uncertain significance (Nov 23, 2021) | |||
Y-1636511-C-T | ASMT-related disorder | Benign (Feb 16, 2021) | ||
Y-1636567-TG-T | ASMT-related disorder | Likely benign (Feb 22, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ASMT | protein_coding | protein_coding | ENST00000381241 | 9 | 28081 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.27e-20 | 0.0000489 | 125160 | 1 | 430 | 125591 | 0.00172 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.70 | 268 | 200 | 1.34 | 0.0000127 | 2398 |
Missense in Polyphen | 75 | 60.822 | 1.2331 | 732 | ||
Synonymous | -2.51 | 122 | 91.5 | 1.33 | 0.00000716 | 743 |
Loss of Function | -2.13 | 25 | 15.8 | 1.58 | 7.61e-7 | 196 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00233 | 0.00233 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000603 | 0.000598 |
Finnish | 0.00402 | 0.00403 |
European (Non-Finnish) | 0.00225 | 0.00224 |
Middle Eastern | 0.000603 | 0.000598 |
South Asian | 0.000653 | 0.000653 |
Other | 0.00179 | 0.00180 |
dbNSFP
Source:
- Function
- FUNCTION: Isoform 1 catalyzes the transfer of a methyl group onto N-acetylserotonin, producing melatonin (N-acetyl-5- methoxytryptamine). Isoform 2 and isoform 3 lack enzyme activity. {ECO:0000269|PubMed:22775292}.;
- Pathway
- Tryptophan metabolism - Homo sapiens (human);Tryptophan Metabolism;Melatonin metabolism and effects;Tryptophan metabolism;Biogenic Amine Synthesis;serotonin and melatonin biosynthesis;Metabolism of amino acids and derivatives;Metabolism;Tryptophan degradation;superpathway of tryptophan utilization;Serotonin and melatonin biosynthesis;Amine-derived hormones
(Consensus)
Intolerance Scores
- loftool
- 0.969
- rvis_EVS
- 0.13
- rvis_percentile_EVS
- 63.57
Haploinsufficiency Scores
- pHI
- 0.0945
- hipred
- N
- hipred_score
- 0.170
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.724
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Asmt
- Phenotype
- reproductive system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- translation;aromatic compound biosynthetic process;melatonin biosynthetic process;methylation;indolalkylamine biosynthetic process
- Cellular component
- cytosol
- Molecular function
- O-methyltransferase activity;S-methyltransferase activity;S-adenosylmethionine-dependent methyltransferase activity;acetylserotonin O-methyltransferase activity;identical protein binding;protein homodimerization activity